MAP1LC3A and cancer: Overall, these findings highlight the complex landscape of CNVs in PRKN, OPTN, PINK1, SRC, BECN1, BNIP3L, and MAP1LC3A across different cancer types, emphasizing the potential impact of these genetic alterations on cancer pathogenesis and the importance of considering CNVs in therapeutic strategies.